Zentek

ZTEK

Market cap $89.1M

Guelph, Ontario--(Newsfile Corp. - October 22, 2025) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company, is pleased to announce, further to its press releases dated October 1, 2025 and October 20, 2025, that it has closed its non-brokered private placement of units (the "Units") through the issuance of 2,338,893 Units at a price of $1.06 per Unit (the "Offering") for gross proceeds of $2,479,227.

Guelph, Ontario--(Newsfile Corp. - October 20, 2025) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company is pleased to announce, further to its press release dated October 1, 2025, its previously announced non-brokered private placement of units (each, a "Unit") at a price of $1.06 per Unit (the "Offering") has been increased to up to 2,358,490 Units for gross proceeds of up to $2,500,000.

GUELPH, ON / ACCESS Newswire / October 6, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company, is pleased to share an update from its wholly owned subsidiary, Albany Graphite Corp. ("AGC") on its Critical Minerals Innovation Fund ("CMIF") grant-funded activities, further to its release dated September 22, 2025.

Guelph, Ontario--(Newsfile Corp. - October 1, 2025) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company, is pleased to announce its intention to complete a non-brokered private placement of up to $2,000,000 through the issuance of up to 1,886,792 units (the "Units") in the capital of the Company at a price of $1.06 per Unit (the "Offering").

Guelph, Ontario--(Newsfile Corp. - September 25, 2025) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property technology development and commercialization company, announces the voting results from its annual and special meeting of shareholders (the "Meeting") held on September 25, 2025.

GUELPH, ONTARIO / ACCESS Newswire / September 24, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN) an intellectual property technology development and commercialization company, is pleased to provide a corporate update.

GUELPH, ON / ACCESS Newswire / September 22, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company, is pleased to share an update from its wholly owned subsidiary, Albany Graphite Corp. ("AGC") on its Critical Minerals Innovation Fund ("CMIF") grant-funded activities.

GUELPH, ONTARIO / ACCESS Newswire / September 18, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), is pleased to announce that it has completed the first in vivo tests of the lead candidate countermeasure for seasonal influenza (H1N1) as part of the Innovative Solutions Canada Testing Stream.

GUELPH, ON / ACCESS Newswire / September 10, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company, today announces that, further to its news release on September 3, 2025, it is updating the slate of director nominees for the upcoming annual general and special meeting to be held on September 25, 2025 (the "Meeting").

GUELPH, ON / ACCESS Newswire / September 3, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company, today announces that Greg Fenton has resigned as Chief Executive Officer ("CEO") and as a member of the Board of Directors, effective immediately, to become the full-time CEO of Altek Advanced Materials Inc. ("Altek"), a Nevada incorporated private company focused on the commercialization of advanced material technologies in the United States, of which Greg Fenton owns more than a 50% beneficial equity interest.